Lv5
1450 积分 2024-02-20 加入
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis
3天前
已完结
Waist-to-hip ratio and nonalcoholic fatty liver disease: a clinical observational and Mendelian randomization analysis
1个月前
已完结
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
2个月前
已完结
Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
2个月前
已完结
A new generation of non-invasive tests of liver fibrosis with improved accuracy in MASLD
3个月前
已完结
Association of inflammatory score with all-cause and cardiovascular mortality in patients with metabolic syndrome: NHANES longitudinal cohort study
3个月前
已完结
Plasma FSTL-1 as a non-invasive diagnostic biomarker for patients with advanced liver fibrosis
3个月前
已完结
Plasma FSTL-1 as a non-invasive diagnostic biomarker for patients with advanced liver fibrosis
4个月前
已完结
Steatotic liver disease
4个月前
已完结
Association between cardiometabolic index and hepatic steatosis and liver fibrosis: a population-based study
4个月前
已完结
皖公网安备34019202002308
